Non‐invasive foetal RhD genotyping: A strategy for rationalizing anti‐D immunoglobulin prophylaxis in RhD ‐negative pregnant women at the Hospital Italiano de Buenos Aires

Documenti analoghi

• Use and availability of anti‐ RhD immunoglobulin in Colombia following the 2024 national shortage
  di: Mariana Barake‐Ramos, et al.
  Pubblicazione: (2026)
• Prediction of the antigenic regions in eight RhD variants identified by computational biology
  di: Rocio Trueba‐Gómez, et al.
  Pubblicazione: (2024)
• Real‐world performance of a clinical droplet digital polymerase chain reaction assay for non‐invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies directed against RhD, RhE, Rhc, RhC, K1, HPA‐1a or HPA‐5b: A 1‐year experience
  di: Camilla Calandrini, et al.
  Pubblicazione: (2024)
• RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study
  di: Takaaki Konuma, et al.
  Pubblicazione: (2024)
• Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti‐D prophylaxis in Rh(D)‐negative pregnant women? A systematic review and meta‐analysis
  di: C. B. M. Ngan, et al.
  Pubblicazione: (2024)